Industry News


Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info



GE Healthcare To Augment Product Dept Capability

Global medical diagnostic major GE Healthcare will be increasing its product development capability and manpower strength in the country shortly.

"India is a key part of our global operations and the country is no longer viewed for its cost arbitrage but for its engineering and information technology expertise. The country accounts for 15 per cent of the total medical diagnostics production for the global major", stated Joseph M. Hogan, president and chief executive officer, GE Healthcare UK during a press interaction arranged on the occasion of his visit to India.

Its latest manufacturing efforts is the MAC 400, a hand held ECG recorder which is expected to revolutionize portable diagnostics in India. MAC 400 is easy to operate. It is lightweight and has the proven clinical accuracy for 12 lead ECG analysis besides a generation of a single sequence report. The device is efficient and can be conveniently taken to the patient’s bed side for the first line of diagnosis by a medical practitioner who would be able to administer necessary action during a cardiac emergency. The company is working to ensure that Mac 400 reaches the 500,000 general physicians apart from the additional 15,000 doctors getting into practice in the country every year. Another two product releases focused on early health model of care are expected to be out by the end of the year, stated V Raja, president Wipro GE Medical Systems and president & chief executive officer, GE Healthcare Technologies, South Asia.

The facility in Bangalore at Whitefield accounts for a third of the total engineering strength. The company is also looking to increase its head count from the current 2,200 personnel. While it added 500 people in 2006, the same numbers could be maintained this year depending on the growth of manufacture.

GE Healthcare with its acquisition of Abbott’s primary in vitro diagnostics and Abbott Point-of-Care business will begin to offer in vitro and in vivo diagnostics capabilities in India. In the Life Sciences space, GE will introduce a range of protein separators chromatography systems to address the needs for the biotech sector.

The company’s radio pharmacy centre in New Delhi has received the clearances from BARC. In the area of imaging agents, a global trial is on at Manipal Hospital for assessing the safety and efficacy.

GE Healthcare South Asia generated revenues to the tune of US $475 million in 2006 with a growth rate of 20 per cent. The company’s expertise includes nuclear medicine, digital diagnostics, ultrasound and IT medical software business. The diagnostic market in the country is valued at $400 million and growing at 15 percent.

(Ref : Chronicle Pharmabiz dated March 22, 2007)


Other News

Govt Plans Regulation Of Retail Pharmacies
Corporate Hospitals See 15% Earnings From Foreign Patients
Heart Connect
Labelling Committee Moots Country Wise Code For Drug Exports
Kitten To Market Timestrip’s Smart Label Technology In India
Medical Devices Being Marketed Without Regulations, Safeguards In India
Borealis Develops Polypropylene BH34MO For Pail Packaging
AMDSI Urges Govt To Reduce Customs Duty, Set Up Medical Tech Park
AIOCD To Float 10 State Wise Pharmacy Retail Chain Cos By 2008
Companies Look To Gain From Budget Proposals
US FDA Nod For Baxter's Colleague Infusion Pump
Polymed Medicure Eyeing US Market





Back | Back To Top | Previous | Next